Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
Factors associated with treatment response in patients with idiopathic inflammatory myopathies. A registry-based study
Espinosa-Ortega F, Holmqvist M, Dastmalchi M, et al.
Arthritis care & research, 2020
Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies
Seto N, Torres-Ruiz JJ, Carmona-Rivera C, et al.
JCI insight, 2020, 5, 3
Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies
Seto NL, Torres-Ruiz JJ, Carmona-Rivera C, et al.
JCI insight, 2020
Pregnancy outcomes in women with idiopathic inflammatory myopathy, before and after diagnosis-a population-based study
Che WI, Hellgren K, Stephansson O, et al.
Rheumatology (Oxford, England), 2020
Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group
Esfandiary T, Park JK, Alexanderson H, et al.
Seminars in arthritis and rheumatism, 2020, 50, 5, p 943
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study
Leclair V, Galindo-Feria AS, Dastmalchi M, et al.
Rheumatology (Oxford, England), 2019
Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort
Barsotti S, Dastmalchi M, Notarnicola A, et al.
Seminars in arthritis and rheumatism, 2019
Idiopathic Inflammatory Myopathies
Vencovsky J, Alexanderson H, Lundberg IE
Rheumatic diseases clinics of North America, 2019, 45, 4, p 569
Reproductive Pattern in Women with Idiopathic Inflammatory Myopathy - a Population-based Study
Che WI, Hellgren K, Lundberg IE, et al.
The Journal of rheumatology, 2019
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
Rothwell S, Chinoy H, Lamb JA, et al.
Annals of the rheumatic diseases, 2019, 78, n7, p 996
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
Betteridge Z, Tansley S, Shaddick G, et al.
Journal of autoimmunity, 2019, 101, p 48
Response to: 'Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al' by Knitza et al
Tjärnlund A, Lundberg IE
Annals of the rheumatic diseases, 2019
Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
Tanboon J, Sanmaneechai O, Charuvanij S, et al.
Neuromuscular disorders : NMD, 2019
Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis.
Boehler JF, Horn A, Novak J, et al.
The Journal of pathology, 2019
Acute coronary syndrome in idiopathic inflammatory myopathies: a population-based study
Leclair V, Svensson J, Lundberg IE, et al.
The Journal of rheumatology, 2019
OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies
Regardt M, Mecoli CA, Park JK, et al.
The Journal of rheumatology, 2019
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Tjärnlund A, Tang Q, Wick C, et al.
Annals of the rheumatic diseases, 2018, 77, 1, p 55
Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study
Dobloug GC, Svensson J, Lundberg IE, et al.
Annals of the rheumatic diseases, 2018, 77, 1
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
Lilleker JB, Vencovsky J, Wang G, et al.
Annals of the rheumatic diseases, 2018, 77, 1, p 30
New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter
Leclair V, Lundberg IE
Current rheumatology reports, 2018, 20, 4
Current Treatment for Myositis
Barsotti S, Lundberg IE
Current treatment options in rheumatology, 2018, 4, 4, p 299
Classification of myositis
Lundberg IE, de Visser M, Werth VP
Nature reviews. Rheumatology, 2018, 14, 5, p 269
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Lundberg IE, Tjärnlund A, Bottai M, et al.
Annals of the rheumatic diseases, 2017, 76, 12, p 1955
Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study
Svensson J, Holmqvist M, Lundberg IE, et al.
Annals of the rheumatic diseases, 2017, 76, 11, p 1803
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis : An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Aggarwal R, Rider LG, Ruperto N, et al.
Annals of the rheumatic diseases, 2017, 76, 5, p 792
